Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Camostat · FOY-305

Small molecule · Inhibitor of Transmembrane protease, serine 2 (TMPRSS2) · developed by Daewoong Pharmaceutical Co.

Phase 2/3 Most advanced trial (none active)
1 Registered trials

What is Camostat?

Camostat is an orally bioavailable synthetic serine protease inhibitor that blocks a range of proteases, including trypsin, kallikrein, thrombin and plasmin, and may inhibit the host protease TMPRSS2 that mediates coronavirus cell entry. It is being studied in COVID-19 (coronavirus infection).

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
FOY-305
Drug type
Small molecule
Targets
Transmembrane protease, serine 2 (TMPRSS2), Trypsin (secondary target), Thrombin (secondary target), Plasmin (secondary target)
Mechanism
Inhibitor of Transmembrane protease, serine 2 (TMPRSS2)
Pathways
trypsinogen activation, inflammatory cytokine signaling, fibrosis, viral cell entry
Therapy area
Infectious disease
Developer
Daewoong Pharmaceutical Co. LTD.
In trials of
SABS
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 2/3
UNII
0FD207WKDU

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT04518410 Phase 2/3 Coronavirus Completed SABS

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

CoronavirusCovid19

Other drugs acting on TMPRSS2

Sources

Updated Nov 1, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.